EVOLVING APPROACHES TO PLANNING AND GUIDING COMPLEX PCI
Details
Intracoronary physiology in complex PCI: applications and current trends
Justin Davies
Contemporary trends in intracoronary imaging to plan and guide PCI
Ziad Ali
Functional coronary angiography: a new approach to planning and guiding PCI
Javier Escaned
Discussion and questions from onsite and online attendees
Learning points at a glance
Organised by
Date
- America/New_York
Dejan Milasinovic
Dr Dejan Milasinovic is an interventional cardiologist at the Department of Cardiology, Clinical...
Read MoreDr Dejan Milasinovic is an interventional cardiologist at the Department of Cardiology, Clinical Center of Serbia. He is also an Assistant Professor at Faculty of Medicine, University of Belgrade. His main research interests focus in the fields of the invasive treatment of acute coronary syndromes and complex coronary interventions, with an emphasis on bifurcation PCI and intracoronary guidance. In 2016, Dr Milasinovic received the EuroPCR 2016 Best Abstract award, for a work on the timing of invasive coronary intervention in patients with non-ST-segment elevation myocardial infarction. He is a member of European Association of Percutaneous Cardiovascular Interventions (EAPCI) and has served as program committee member of the annual EuroPCR conference. Dr Milasinovic also serves on the editorial boards of EuroIntervention (editorial consultant) and PCRonline and is the Chair of the EAPCI Young committee.
Show LessJavier Escaned
Prof Javier Escaned is Head of Section (Interventional Cardiology Section) at Hospital Clinico...
Read MoreProf Javier Escaned is Head of Section (Interventional Cardiology Section) at Hospital Clinico San Carlos / Complutense University (Madrid, Spain). He trained in the United Kingdom as Specialist in Cardiology and obtained his PhD in The Netherlands. Author of >600 indexed scientific articles on interventional cardiology, imaging and physiology (h-index 74) and over 30 years of experience as PCI operator, he regularly lectures and performs live cases at major scientific and educational meetings. He is a recipient of the European Society of Cardiology (ESC) Silver Medal and the Andreas Grüntzig Award for his contributions to the fiedl fo Interventional Cardiology. Main areas of expertise include complex PCI, intracoronary diagnostics and functional coronary angiography. His track record in coronary physiology comprises being investigator on pioneer FFR trials like DEFER (1998), collaborator with Justin Davies in the validation and clinical implementation of iFR, and developer of new tools for the assessment of coronary microcirculation. Editorial roles include Deputy Editor EHJ, Advisory Editor Eurointervention, editor of the textbooks “Coronary Stenosis: Imaging, Structure and Physiology” and “Physiological Assessment of Coronary Stenoses and the Microcirculation". Recent board positions include EAPCI board / Education Committee Chair, ESC WG Coronary Pathophysiology and Microcirculation, EuroCTO Board. Recent trials as Principal Investigator include ADVISE II, DEFINE FLAIR, SYNTAX II, PIONEER IV, Cerebral-Coronary-Connection (C3), DCR4Contrast, INOCA LongCovid and AID ANGIO. Additional interests are philosophy and music.
Show LessJustin Davies
Dr Justin Davies is a honorary interventional cardiologist at Hammersmith Hospital, Imperial...
Read MoreDr Justin Davies is a honorary interventional cardiologist at Hammersmith Hospital, Imperial College NHS Trust, London. After training at Imperial College, he won a prestigious BHF research fellowship to study arterial haemodynamics. Since then he has continued to work on the development of mathematical algorithms to aid understanding of large artery physiology and to develop new tools to assess arterial disease. The holder of several patents, he has published widely in the field of hypertension, coronary and large artery physiology and is the winner of many national and international awards. He has several international collaborations, and is the developer of iFR and the co-principal investigator of the ADVISE studies, the DEFINE-FLAIR, ORBITA and DEFINE-PCI studies. Justin also has an interest in renal denervation, and has lead the first-in-man studies to evaluate the safety of this technique to patients with chronic systolic heart failure (REACH studies).
Show LessKambis Mashayekhi
Dr Kambis Mashayekhi is Head of the Department of Internal Medicine and Cardiology in Heart...
Read MoreDr Kambis Mashayekhi is Head of the Department of Internal Medicine and Cardiology in Heart Center Lahr in Germany. Dr. Mashayekhi is performing over 350 CTO-PCI’s per year and is an world-renowned CTO and complex PCI specialist. Dr. Mashayekhi is the head of the CTO working group from the German Society of cardiology and the Co-Director of MLCTO and EuroCTO course. He is the new EuroCTO president elect for 2023.
Show LessRichard Shlofmitz
Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The...
Read MoreDr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The Heart Center®, in Roslyn, New York. A pioneer in interventional cardiology, Dr. Shlofmitz has worked to advance the field, with a focus on optimizing outcomes with the development of Precision PCI. He is a founding co-director of the annual Intravascular Imaging and Coronary Physiology Workshop. Performing over 1,000 coronary interventions annually, he has one of the largest volumes of experience in PCI. He has the most clinical experience with orbital atherectomy and OCT world-wide. His clinical research interests focus on optimizing coronary interventions and he serves on multiple scientific advisory boards and clinical trial steering committees to further this mission. Dr Shlofmitz has been one of the largest enrollers for multiple clinical trials, including TWILIGHT, ILUMIEN III, and Onyx, with more than 75 publications in peer-reviewed journals and was first to perform coronary intravascular lithotripsy (IVL) in North America as part of the DISRUPT CAD III trial.
Show LessVijay Kunadian
Prof Kunadian is a Professor of Interventional Cardiology holding a Personal Chair at Newcastle...
Read MoreProf Kunadian is a Professor of Interventional Cardiology holding a Personal Chair at Newcastle University and Honorary Academic Consultant Interventional Cardiologist Freeman Hospital, Newcastle upon Tyne, UK. Prof Kunadian has an international reputation in interventional cardiology and cardiovascular research, making her a sought-after and respected speaker at prominent national and international meetings. She has championed diversity in her specialty as a role model; only 5% of interventional cardiologist are female in the UK, <1% are clinical academics/researchers and only female interventional cardiologist holding a University Personal Chair. She is also recipient of the UK Department of Health National Clinical Excellence Bronze Award. She is UK Chief Investigator in many multicentre clinical trials with major grant awards including from the British Heart Foundation. She has published >180 peer reviewed publications in major journals. She is UK’s 1st female to be appointed as the British Cardiovascular Intervention Society Research and Development Working Group lead. She has been chosen by the British Heart Foundation as their panel member for the Bias and Biology Campaign addressing the disparity of care among female patients with heart disease. She was the Chair/Lead author on the ESC/EAPCI Consensus document on INOCA which has raised the awareness of this condition worldwide. She has campaigned on the national media including the BBC, ITV, Channel 4 and newspapers to improve the care of patients with heart disease in particular women and heart disease. She is one of the commissioners on the Lancet Commission to reduce the global burden of heart disease in women by 2030. She was awarded Winner of the UK Times and the Sunday Times We Are The City Rising Star Award for 2018. In 2022 she was nominated for the British Heart Foundation Heart Hero Research Engagement Award. She was also nominated for the 2023 Northern Power Women Awards- Disruptor Good Category.
Show LessZiad Ali
Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational...
Read MoreZiad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational Interventional Cardiology, and Director of Cardio-nephrology at St Francis Hospital & Heart Center in New York. He is also Director of the Angiographic Core Laboratory at Cardiovascular Research Foundation and Associate Professor of Medicine at Columbia University Medical Center. His clinical research interests focus on the use of intravascular imaging and physiology technologies such as optical coherence tomography, intravascular ultrasound, and flow wire assessment to optimize coronary interventions, for which he has served as a Global principal investigator on a number of trials. Dr. Ali is also a recognized innovator, playing an integral role in the development of the Resting Full-Cycle Ratio (RFR) and Shockwave intravascular lithotripsy. Clinically Dr. Ali developed pioneering techniques to perform vascular interventions without contrast administration, including IVUS-guided zero-contrast PCI and OCT using saline flush media, protecting patients with advanced kidney disease from acute kidney injury and the need for dialysis.
Show Less